scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Erich Gulbins | Q37611826 |
P2093 | author name string | Pin Lan Li | |
P2860 | cites work | Reactive oxygen species limit neutrophil life span by activating death receptor signaling | Q44967331 |
Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2*- production in the intact coronary endothelium | Q45096402 | ||
Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells | Q45116558 | ||
Sphingosine 1-phosphate breakdown in platelets | Q45206456 | ||
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate | Q45291431 | ||
Stimulation of erythrocyte ceramide formation by platelet-activating factor | Q45291465 | ||
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected] | Q46842083 | ||
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway | Q46885906 | ||
CD95 rapidly clusters in cells of diverse origins | Q47607398 | ||
Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death | Q47954345 | ||
Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. | Q48970037 | ||
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. | Q49165929 | ||
Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. | Q50527419 | ||
The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups. | Q50931581 | ||
Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. | Q51662176 | ||
Ceramide enables fas to cap and kill. | Q52542714 | ||
Host acid sphingomyelinase regulates microvascular function not tumor immunity. | Q53879620 | ||
Observation of Topical Catalysis by Sphingomyelinase Coupled To Microspheres | Q57365739 | ||
Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria | Q57369563 | ||
Ceramide-mediated clustering is required for CD95-DISC formation | Q57369954 | ||
CD95 Signaling via Ceramide-rich Membrane Rafts | Q57371964 | ||
UV-C Light Induces Raft-associated Acid Sphingomyelinase and JNK Activation and Translocation Independently on a Nuclear Signal | Q57372335 | ||
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients | Q57375076 | ||
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling | Q58435118 | ||
Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte | Q59192165 | ||
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations | Q22254363 | ||
Cathepsin D targeted by acid sphingomyelinase-derived ceramide | Q24529823 | ||
Cholesterol, lipid rafts, and disease | Q24553188 | ||
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis | Q24679716 | ||
Functional rafts in cell membranes | Q27860768 | ||
Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene | Q28116333 | ||
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy | Q28140319 | ||
Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death | Q28213775 | ||
Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring | Q28219852 | ||
The fluid mosaic model of the structure of cell membranes | Q28239890 | ||
Expression of the Leo1-like domain of replicative senescence down-regulated Leo1-like (RDL) protein promotes senescence of 2BS fibroblasts | Q28241741 | ||
Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation | Q28284440 | ||
Kinase suppressor of Ras is ceramide-activated protein kinase | Q28307245 | ||
Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis | Q28361609 | ||
Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells | Q28570949 | ||
Vav2 is an activator of Cdc42, Rac1, and RhoA | Q28610652 | ||
The caveolae membrane system | Q29614726 | ||
NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
Functions of lipid rafts in biological membranes | Q29616845 | ||
Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy | Q30044494 | ||
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice | Q30881683 | ||
Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine | Q31145560 | ||
Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. | Q31629166 | ||
Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion | Q33640387 | ||
Apoptosis in myocardial ischemia-reperfusion. | Q33692497 | ||
Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha | Q42162100 | ||
Ceramide: a novel cell signaling mechanism for vasodilation | Q42443114 | ||
LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions | Q42460475 | ||
Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide | Q42483715 | ||
Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle | Q42485139 | ||
Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel | Q42494359 | ||
Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats | Q42505746 | ||
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. | Q42555356 | ||
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles | Q42825650 | ||
Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. | Q43508241 | ||
Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback mechanism regulating cell death | Q43510191 | ||
Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries | Q43590614 | ||
Molecular mechanisms of ceramide-mediated CD95 clustering | Q43642943 | ||
Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux | Q43752274 | ||
Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase | Q43818610 | ||
De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. | Q43860697 | ||
PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells | Q43997285 | ||
Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries | Q44182978 | ||
Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries | Q44210993 | ||
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts | Q44300453 | ||
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells | Q44539962 | ||
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. | Q44712899 | ||
Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death | Q44757012 | ||
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide | Q33807705 | ||
Apoptotic mechanisms in acute renal failure | Q33887907 | ||
Physiology and pathophysiology of sphingolipid metabolism and signaling | Q33930354 | ||
Involvement of sphingomyelinases in TNF signaling pathways | Q34042929 | ||
Participation of Rac GTPase activating proteins in the deactivation of the phagocytic NADPH oxidase | Q34145139 | ||
Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein | Q34206300 | ||
Membrane lipid microdomains and the role of PKCtheta in T cell activation | Q34222554 | ||
Current perspective on the role of apoptosis in atherothrombotic disease | Q34262829 | ||
Sphingolipid mediators in cardiovascular cell biology and pathology | Q34444896 | ||
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta | Q34555162 | ||
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. | Q34731655 | ||
Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
Pathogens: raft hijackers | Q35183159 | ||
Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system | Q35561571 | ||
Imaging immune cell interactions and functions: SMACs and the Immunological Synapse | Q35682734 | ||
Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity | Q36048670 | ||
CD28 signals through acidic sphingomyelinase | Q36364947 | ||
Phospholipid unsaturation and plasma membrane organization | Q36406415 | ||
Calcium-independent activation of endothelial nitric oxide synthase by ceramide | Q36546570 | ||
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides | Q36657235 | ||
Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases | Q36664164 | ||
Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. | Q36701948 | ||
Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation | Q38346649 | ||
Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide | Q39451271 | ||
Epidermal growth factor receptors | Q40124107 | ||
Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. | Q40311939 | ||
TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx | Q40437294 | ||
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells | Q40504942 | ||
Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts. | Q40546049 | ||
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. | Q40554384 | ||
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains | Q40559235 | ||
Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells | Q40775470 | ||
CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa | Q40847899 | ||
Induction of tissue factor production but not the upregulation of adhesion molecule expression by ceramide in human vascular endothelial cells | Q40853739 | ||
Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex | Q40858625 | ||
Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae | Q40863681 | ||
Intracellular mechanisms of L-selectin induced capping | Q40947615 | ||
Interactions between the components of the human NADPH oxidase: intrigues in the phox family | Q41195261 | ||
Phosphorylation of Raf by ceramide-activated protein kinase | Q41270560 | ||
Role for ceramide in cell cycle arrest. | Q41370969 | ||
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. | Q41440948 | ||
Surgical implications of vascular endothelial physiology | Q41600713 | ||
Co-capping of ras proteins with surface immunoglobulins in B lymphocytes | Q41721096 | ||
Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. | Q41725574 | ||
Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways | Q41846875 | ||
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. | Q41855472 | ||
P433 | issue | 1 | |
P921 | main subject | ceramides | Q424213 |
pathophysiology | Q1135939 | ||
P304 | page(s) | R11-26 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
P1476 | title | Physiological and pathophysiological aspects of ceramide | |
P478 | volume | 290 |
Q37870853 | Acid sphingomyelinase in macrophage biology |
Q40637739 | Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis |
Q47241393 | Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis |
Q28570875 | Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction |
Q92327433 | Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease |
Q90250063 | Association of Circulating Ceramides With Cardiac Structure and Function in the Community: The Framingham Heart Study |
Q36911424 | Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length |
Q98665063 | C24:0 and C24:1 sphingolipids in cholesterol-containing, five- and six-component lipid membranes |
Q53210411 | Ca2+ -regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells. |
Q38132083 | Cadmium and cellular signaling cascades: interactions between cell death and survival pathways |
Q33903791 | Cancer models in Caenorhabditis elegans |
Q28078167 | Cell membrane modulation as adjuvant in cancer therapy |
Q46625497 | Ceramide and raft signaling are linked with each other in UVA radiation-induced gene expression |
Q42936816 | Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans |
Q37884074 | Ceramide formation as a target in beta-cell survival and function |
Q37797406 | Ceramide in stress response |
Q37433922 | Ceramide mediates acute oxygen sensing in vascular tissues |
Q36803735 | Ceramide signaling in cancer and stem cells |
Q38124070 | Ceramides in the pathophysiology of the anterior segment of the eye. |
Q37364329 | Ceramides: a potential therapeutic target in pulmonary emphysema |
Q53731153 | Characterization of Plasma Membrane Ceramides by Super-Resolution Microscopy. |
Q34712835 | Characterization of acid sphingomyelinase activity in human cerebrospinal fluid |
Q41773170 | Cholesterol: A modulator of the phagocyte NADPH oxidase activity - A cell-free study |
Q37066909 | Contribution of acid sphingomyelinase in the periaqueductal gray region to morphine-induced analgesia in mice |
Q37149419 | Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction |
Q27657233 | Crystal Structure of the Salmonella enterica Serovar Typhimurium Virulence Factor SrfJ, a Glycoside Hydrolase Family Enzyme |
Q45960422 | Development of a novel FRET probe for the real-time determination of ceramidase activity. |
Q34651154 | Diaphragm dysfunction caused by sphingomyelinase requires the p47(phox) subunit of NADPH oxidase |
Q48108641 | Differential effects of ceramide species on exocytosis in rat PC12 cells |
Q37880161 | Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases |
Q40287482 | Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection |
Q36848106 | Effect of irradiation on microvascular endothelial cells of parotid glands in the miniature pig |
Q50220852 | Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion. |
Q30493572 | Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes |
Q39929088 | Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach |
Q33733353 | Expression and regulation of enzymes in the ceramide metabolic pathway in human retinal pigment epithelial cells and their relevance to retinal degeneration |
Q48378033 | Expression, activity, and role of serine palmitoyltransferase in the rat hippocampus after kainate injury. |
Q42700766 | Extracellular sphingomyelinase activity impairs TNF-α-induced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding |
Q39951842 | Fluorescent annexin A1 reveals dynamics of ceramide platforms in living cells |
Q37118990 | Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury |
Q40101092 | Fructose-induced stress signaling in the liver involves methylglyoxal |
Q38273069 | Glucosylceramide Reorganizes Cholesterol-Containing Domains in a Fluid Phospholipid Membrane |
Q37527686 | Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies |
Q30531999 | Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host response |
Q21003953 | Identification of novel functional inhibitors of acid sphingomyelinase |
Q26852322 | Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons |
Q35989359 | Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid |
Q33897978 | Instant membrane resealing in nlrp3 inflammmasome activation of endothelial cells. |
Q51748862 | Intracellular Ca(2+) operates a switch between repair and lysis of streptolysin O-perforated cells. |
Q35101890 | Lipid raft redox signaling: molecular mechanisms in health and disease |
Q39578642 | Lipid raft-dependent activation of dual oxidase 1/H2O2/NF-κB pathway in bronchial epithelial cells |
Q37951442 | Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis |
Q52890205 | Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. |
Q37157907 | Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells |
Q35883894 | Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells |
Q34131213 | Lysosome-membrane fusion mediated superoxide production in hyperglycaemia-induced endothelial dysfunction |
Q42531983 | Mechanisms involved in cellular ceramide homeostasis |
Q37118254 | Membrane raft redox signalosomes in endothelial cells |
Q35040700 | Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. |
Q27320039 | Microvesicle shedding and lysosomal repair fulfill divergent cellular needs during the repair of streptolysin O-induced plasmalemmal damage |
Q38125279 | Molecular biology of atherosclerosis |
Q37448829 | Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages |
Q34985463 | Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury. |
Q52725132 | Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction. |
Q24316872 | Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies |
Q36747028 | Novel role of sphingolipid synthesis genes in regulating giardial encystation |
Q38900872 | Nrf2 up-regulates the induction of acidic sphingomyelinase by electrophiles |
Q39804008 | Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease |
Q33727276 | Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion |
Q89530316 | Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study |
Q42954809 | Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis |
Q41978852 | Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta |
Q34285232 | Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. |
Q34787157 | Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase |
Q37454661 | Roles and regulation of secretory and lysosomal acid sphingomyelinase |
Q35543506 | SNARE-mediated rapid lysosome fusion in membrane raft clustering and dysfunction of bovine coronary arterial endothelium. |
Q35780081 | Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis |
Q27488402 | Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities |
Q91890020 | Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides |
Q37652733 | Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction |
Q35750931 | Sphingolipids in cardiovascular diseases and metabolic disorders |
Q44965785 | Sphingolipids in the lungs. |
Q33337132 | Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. |
Q45986616 | Sphingomyelinase dependent apoptosis following treatment of pancreatic beta-cells with amyloid peptides Abeta(1-42) or IAPP. |
Q35994710 | Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers |
Q34149763 | Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue |
Q54565672 | Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. |
Q50241212 | The endothelium in hypoxic pulmonary vasoconstriction. |
Q37624460 | The role of ceramide in major depressive disorder |
Q36905995 | The role of fatty acids in the development and progression of nonalcoholic fatty liver disease |
Q27323504 | The targeting of plasmalemmal ceramide to mitochondria during apoptosis |
Q46307666 | Tin triggers suicidal death of erythrocytes |
Q43120232 | Triggering of dendritic cell apoptosis by xanthohumol |
Q30493665 | Triggering role of acid sphingomyelinase in endothelial lysosome-membrane fusion and dysfunction in coronary arteries. |
Q53543465 | Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. |
Q41687237 | Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection |
Q36199812 | oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages. |
Search more.